U.S., Aug. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07112287) titled 'Germline Testing for Predisposition to Myeloid Malignancies' on Aug. 01.
Brief Summary: The goal of this research study is to evaluate the feasibility of germline genetic testing using the investigational MyeloGen Gene Panel in adult participants diagnosed with myeloid malignancies.
Study Start Date: Feb., 2026
Study Type: INTERVENTIONAL
Condition:
Myeloid Malignancy
Genetic Predisposition to Disease
Myeloid Hematological Malignancies
Intervention:
DEVICE: MyeloGen Gene Panel
The MyeloGen Gene Panel is investigational Germline genetic testing using skin fibroblasts.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Christopher...